{"id":"W2082461176","doi":"10.1002/ana.22316","title":"Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Medicine; Tolerability; Multiple sclerosis; Clinical endpoint; Confidence interval; Expanded Disability Status Scale; Internal medicine; Randomized controlled trial; Magnetic resonance imaging; Adverse effect; Radiology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002070411,0.001501719,0.00260551,0.0005168139,0.0002630762,0.0008399012,0.00102971,0.001355518,0.004187176],"category_scores_gemma":[0.001408694,0.0005555043,0.001407032,0.0005002629,0.0007210204,0.0006664647,0.0002878538,0.002354483,0.0008588948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007534412,"about_ca_system_score_gemma":0.0009514885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004999206,"about_ca_topic_score_gemma":0.001024293,"domain_scores_codex":[0.9992774,0.0004348425,0.00003835009,0.00009461688,0.00008248932,0.00007231491],"domain_scores_gemma":[0.9992095,0.0002102962,0.0002836015,0.00007847972,0.00004311922,0.0001749701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9276461,0.01919305,0.001486467,0.0005468272,0.002103594,0.00006818558,0.00006130254,0.0009844148,0.0165078,0.00009606103,0.0007468959,0.03055936],"study_design_scores_gemma":[0.7665625,0.2233232,0.005405144,0.00002960676,0.0007281908,0.00009482407,0.00001907599,0.0006474847,0.002015826,0.0001076508,0.001048128,0.00001830919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894264,0.004923995,0.0007732517,0.0004131347,0.0002211734,0.002264692,0.0008658287,0.0001484294,0.000963111],"genre_scores_gemma":[0.9890192,0.002496695,0.001679404,0.0009528903,0.0002393617,0.002689276,0.0008745664,0.00003423481,0.002014321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004187176,"threshold_uncertainty_score":0.01400745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.307229721040198,"score_gpt":0.4531105052399868,"score_spread":0.1458807841997888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}